{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:37:25Z","timestamp":1793047045369,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10549-026-08096-z","type":"journal-article","created":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T07:44:17Z","timestamp":1793000657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 receptor agonist\u2013associated weight loss in breast cancer patients receiving concurrent endocrine therapy: a retrospective cohort analysis"],"prefix":"10.1007","volume":"220","author":[{"given":"Keri Morgan","family":"Cronin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Tiersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,26]]},"reference":[{"key":"8096_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S et al (2021) Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384:989\u20131002","journal-title":"N Engl J Med"},{"key":"8096_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN et al (2022) Tirzepatide once weekly for the treatment of obesity. N Engl J Med 387:205\u2013216","journal-title":"N Engl J Med"},{"key":"8096_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D et al (2016) Body fatness and cancer \u2014 viewpoint of the IARC Working Group. N Engl J Med 375:794\u2013798","journal-title":"N Engl J Med"},{"key":"8096_CR4","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1200\/JCO.2001.19.9.2381","volume":"19","author":"W Demark-Wahnefried","year":"2001","unstructured":"Demark-Wahnefried W, Peterson BL, Winer EP et al (2001) Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19:2381\u20132389","journal-title":"J Clin Oncol"},{"key":"8096_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1467-789X.2010.00805.x","volume":"12","author":"V Vance","year":"2011","unstructured":"Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12:282\u2013294","journal-title":"Obes Rev"},{"key":"8096_CR6","first-page":"1817","volume":"30","author":"W He","year":"2012","unstructured":"He W, Fang F, Varnum C et al (2012) Predictors of discontinuation of adjuvant hormone therapy in patients with breast cancer. J Clin Oncol 30:1817\u20131823","journal-title":"J Clin Oncol"},{"key":"8096_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.metabol.2014.06.018","volume":"63","author":"JPH Wilding","year":"2014","unstructured":"Wilding JPH (2014) The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors. Metabolism 63:1228\u20131237","journal-title":"Metabolism"},{"key":"8096_CR8","unstructured":"Tronieri JS, Wadden TA, Chao AM et al (2023) Effects of semaglutide versus placebo, combined with intensive behavioral treatment, on body weight, eating, and other outcomes in adults with overweight or obesity. [STEP 1 postmenopausal subgroup]"},{"key":"8096_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM et al (2022) SURMOUNT-1 postmenopausal subgroup analysis. N Engl J Med 387:205\u2013216","journal-title":"N Engl J Med"},{"key":"8096_CR10","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ijo.2013.120","volume":"37","author":"TA Wadden","year":"2013","unstructured":"Wadden TA, Hollander P, Klein S et al (2013) Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss. Int J Obes 37:1443\u20131451","journal-title":"Int J Obes"},{"key":"8096_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35897","author":"S Shen","year":"2025","unstructured":"Shen S, Gogineni K, Bhatt DL et al (2025) GLP-1 receptor agonist use and weight change in patients with breast cancer. Cancer. https:\/\/doi.org\/10.1002\/cncr.35897","journal-title":"Cancer"},{"issue":"3","key":"8096_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1158\/2767-9764.CRC-25-0554","volume":"6","author":"JS Sukumar","year":"2026","unstructured":"Sukumar JS, Raghavendra AS, Pasyar S et al (2026) Weight loss patterns and clinical outcomes of GLP-1 receptor agonists in breast cancer survivors. Cancer Res Commun 6(3):447\u2013455. https:\/\/doi.org\/10.1158\/2767-9764.CRC-25-0554","journal-title":"Cancer Res Commun"},{"issue":"5","key":"8096_CR13","doi-asserted-by":"publisher","first-page":"e2413507","DOI":"10.1001\/jamanetworkopen.2024.13507","volume":"7","author":"AM Navar","year":"2024","unstructured":"Navar AM, Roe MT, Ahmad T et al (2024) GLP-1 receptor agonist use and recurrence-free and overall survival in patients with breast cancer and obesity on hormonal therapy. JAMA Netw Open 7(5):e2413507. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.13507","journal-title":"JAMA Netw Open"},{"key":"8096_CR14","unstructured":"Urueta-Portillo A et al Weight loss outcomes associated with GLP-1 receptor agonist use in breast cancer patients receiving endocrine therapy. [2025 publication]"},{"key":"8096_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","volume":"123","author":"M Protani","year":"2010","unstructured":"Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer. Breast Cancer Res Treat 123:627\u2013635","journal-title":"Breast Cancer Res Treat"},{"key":"8096_CR16","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DSM Chan","year":"2014","unstructured":"Chan DSM, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer. Ann Oncol 25:1901\u20131914","journal-title":"Ann Oncol"},{"key":"8096_CR17","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1200\/JCO.2014.58.4680","volume":"32","author":"JA Ligibel","year":"2014","unstructured":"Ligibel JA, Alfano CM, Courneya KS et al (2014) ASCO position statement on obesity and cancer. J Clin Oncol 32:3568\u20133574","journal-title":"J Clin Oncol"},{"issue":"suppl 16","key":"8096_CR18","doi-asserted-by":"publisher","first-page":"abstract629","DOI":"10.1200\/JCO.2026.44.16_suppl.629","volume":"44","author":"JS Sukumar","year":"2026","unstructured":"Sukumar JS, Niu J, Jackson I, Raghavendra AS, Lim B, Basen-Engquist K, Giordano SH (2026) Real-world treatment patterns and mortality associated with GLP-1 RAs in breast cancer patients. J Clin Oncol 44(suppl 16):abstract629","journal-title":"J Clin Oncol"},{"key":"8096_CR19","unstructured":"Adamson B et al Weight loss outcomes with glucagon-like peptide-1 receptor agonists in patients with breast cancer. Presented at: 2025 San Antonio Breast Cancer Symposium; December 9\u201313, 2025; San Antonio, TX. Abstract PD8-02"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08096-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08096-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:02:35Z","timestamp":1793044955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08096-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,26]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8096"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08096-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,26]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"17"}}